CD8+TILs can exert anti-tumor functions (11) through several pathways such as the release of GZMA and GZMB, Fas-Fas ligand pathway-mediated apoptosis (14, 15), and secretion of inflammatory cytokines like IFN-γ (16) and TNF-α (17). Here, FAS is linked to neoplasm.